Trademark Search
Owners
Global Blood Therapeutics, Inc.
SCRIBE SICKLE CELL RECORD OF DAILY SYMPTOM BURDEN
no statement of use filed
on 25 Mar 2019
Last Applicant/ Owned by
171 Oyster Point Blvd., Suite 300
South San Francisco
CA
94080
Serial Number
87617605 filed on 21st Sep 2017
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"SICKLE CELL RECORD OF DAILY SYMPTOM BURDEN"
Downloadable computer software used to provide computerized adaptive tests regarding patient symptoms and outcomes in clinical practice and research; downloadable scientific and medical data via the internet Questionnaires on patient self-reported data to be used as tools for measurement of patient reported symptoms and other health outcomes in clinical practice and research "SICKLE CELL RECORD Read More
Downloadable computer software used to provide computerized adaptive tests regarding patient symptoms and outcomes in clinical practice and research; downloadable scientific and medical data via the internet
Questionnaires on patient self-reported data to be used as tools for measurement of patient reported symptoms and other health outcomes in clinical practice and research
Providing a database featuring information in the field of chronic diseases that allows the collection of data and information all for treatment diagnostic purposes and research and resources for measurement of patient report symptoms and other health outcomes in clinical practice and research
No 87617605
No Service Mark
No 392886-1
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Mar 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
25th Mar 2019 | ABANDONMENT - NO USE STATEMENT FILED |
21st Aug 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
26th Jun 2018 | PUBLISHED FOR OPPOSITION |
26th Jun 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
06th Jun 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
21st May 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
21st May 2018 | EXAMINERS AMENDMENT -WRITTEN |
21st May 2018 | EXAMINER'S AMENDMENT ENTERED |
21st May 2018 | EXAMINERS AMENDMENT E-MAILED |